These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7566518)

  • 21. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses.
    Costain DW; Cowen PJ; Gelder MG; Grahame-Smith DG
    Lancet; 1982 Aug; 2(8295):400-4. PubMed ID: 6124803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AVP- and OT-neurophysins response to apomorphine and clonidine in major depression.
    Scantamburlo G; Hansenne M; Fuchs S; Pitchot W; Pinto E; Reggers J; Ansseau M; Legros JJ
    Psychoneuroendocrinology; 2005 Oct; 30(9):839-45. PubMed ID: 15964147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone response to growth hormone-releasing hormone and clonidine in depression.
    Gann H; Riemann D; Stoll S; Berger M; Müller WE
    Biol Psychiatry; 1995 Sep; 38(5):325-9. PubMed ID: 7495927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone response to low-dose apomorphine in restless legs syndrome.
    Happe S; Bachmann CG; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
    Growth Horm IGF Res; 2007 Aug; 17(4):323-7. PubMed ID: 17512770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The growth hormone response to clonidine in acute and remitted depressed male patients.
    Siever LJ; Trestman RL; Coccaro EF; Bernstein D; Gabriel SM; Owen K; Moran M; Lawrence T; Rosenthal J; Horvath TB
    Neuropsychopharmacology; 1992 May; 6(3):165-77. PubMed ID: 1599607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catecholamine and HPA axis dysfunction in depression: relationship with suicidal behavior.
    Pitchot W; Reggers J; Pinto E; Hansenne M; Ansseau M
    Neuropsychobiology; 2003; 47(3):152-7. PubMed ID: 12759559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multihormonal responses to apomorphine in mental illness.
    Mokrani MC; Duval F; Crocq MA; Bailey PE; Macher JP
    Psychoneuroendocrinology; 1995; 20(4):365-75. PubMed ID: 8532820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone and physiological responses to clonidine in depression.
    Katona CL; Healy D; Paykel ES; Theodorou AE; Lawrence KM; Whitehouse A; White B; Horton RW
    Psychol Med; 1993 Feb; 23(1):57-63. PubMed ID: 8475215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
    Meltzer HY; Kolakowska T; Fang VS; Fogg L; Robertson A; Lewine R; Strahilevitz M; Busch D
    Arch Gen Psychiatry; 1984 May; 41(5):512-9. PubMed ID: 6721674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apomorphine induced alteration in corneofundal potentials in depression.
    Demet EM; Albers L; Sokolski KN; Chicz-Demet A; Chen CC; Reist C
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jul; 21(5):775-88. PubMed ID: 9278949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
    Happe S; Tings T; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
    Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catecholaminergic function and P300 amplitude in major depressive disorder (P300 and catecholamines).
    Hansenne M; Pitchot W; Gonzalez Moreno A; Papart P; Timsit-Berthier M; Ansseau M
    Electroencephalogr Clin Neurophysiol; 1995 Mar; 96(2):194-6. PubMed ID: 7535224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation.
    Brambilla F; Bellodi L; Perna G; Arancio C; Bertani A
    Biol Psychiatry; 1997 Nov; 42(10):889-97. PubMed ID: 9359974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone and prolactin response to apomorphine in bipolar and unipolar depression.
    McPherson H; Walsh A; Silverstone T
    J Affect Disord; 2003 Sep; 76(1-3):121-5. PubMed ID: 12943941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of growth hormone response after clonidine and insulin hypoglycemia in affective illness.
    Amsterdam JD; Maislin G
    Biol Psychiatry; 1990 Aug; 28(4):308-14. PubMed ID: 2204433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of methyltestosterone on the growth hormone response to the dopamine receptor agonist, apomorphine.
    Lal S; Nair NP; Thavundayil JX; Tawar V; Guyda H; Ayotte C
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):263-8. PubMed ID: 1871327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone response to clonidine in untreated depressed patients.
    Schittecatte M; Charles G; Machowski R; Wilmotte J
    Psychiatry Res; 1989 Aug; 29(2):199-206. PubMed ID: 2798598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of the dopaminergic system in depression: clinical correlates of the apomorphine test].
    Pitchot W; Gonzalez Moreno A; Hansenne M; Wauthy J; Ansseau M
    Acta Psychiatr Belg; 1993; 93 Spec No():343-58. PubMed ID: 7916521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GABA, depression and the mechanism of action of antidepressant drugs: a neuroendocrine approach.
    Monteleone P; Maj M; Iovino M; Steardo L
    J Affect Disord; 1990 Sep; 20(1):1-5. PubMed ID: 2174069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.